The aortic aneurysm market size has grown strongly in recent years. It will grow from $3.74 billion in 2024 to $4.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to the aging population, the prevalence of cardiovascular diseases, improvements in diagnostic technologies, surgical advancements, and awareness programs.
The aortic aneurysm market size is expected to see rapid growth in the next few years. It will grow to $6.02 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to a rising global aging population, increased incidence of cardiovascular diseases, advancements in treatment modalities, genetic predisposition awareness, and healthcare infrastructure development. Major trends in the forecast period include the development of next-generation stent grafts, technological integration for remote monitoring, the prevalence of abdominal aortic aneurysms (AAA), and collaborations in research and development.
The anticipated rise in alcohol and tobacco usage is projected to drive the aortic aneurysm market in the future. Both alcohol and nicotine-containing tobacco products are psychoactive substances impacting the body's central nervous system. The increased consumption of these substances stands as a primary contributor to aortic aneurysms. As per a May 2022 report by the World Health Organization (WHO), an international public health agency headquartered in Switzerland, an estimated 3 million deaths annually are attributed to alcohol consumption, while 7 million deaths occur globally due to tobacco use. Moreover, approximately 13.5% of deaths among individuals aged 20-39 are linked to alcohol consumption. In 2021, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that 11.5% of US adults aged 18 or older were current cigarette smokers, amounting to 28.3 million adults. Hence, the increasing prevalence of alcohol and tobacco consumption is a key driver for the growth of the aortic aneurysm market.
The escalating occurrence of cardiovascular diseases is expected to fuel growth in the aortic aneurysm market. Cardiovascular diseases encompass a range of conditions affecting the heart or blood vessels. Devices tailored for aortic aneurysm treatment significantly contribute to managing cardiovascular diseases, especially those involving aortic aneurysms. For instance, data from May 2023 by the World Heart Federation, a non-governmental organization headquartered in Switzerland, indicated that in 2020, cardiovascular diseases led to 18.9 million fatalities, with forecasts indicating a rise to 22.2 million by 2030 and a further increase to 32.3 million by 2050. Consequently, the increasing incidence of cardiovascular diseases serves as a driving force behind the expansion of the aortic aneurysm market.
Technological advancements have become a prominent trend gaining traction in the aortic aneurysm market. Major companies in this sector are developing and implementing innovative technologies to solidify their market position. For example, in June 2024, Medtronic plc, a medical technology company based in Ireland, introduced the Steerant aortic guidewire, a device designed to enhance precision in aortic procedures. This flexible and advanced tool offers improved maneuverability and control during catheterization, allowing clinicians to navigate complex anatomical pathways more effectively and achieve better patient outcomes. Its goal is to reduce procedural time and minimize complications during aortic interventions.
Major companies in the aortic aneurysm market are concentrating on designing and introducing innovative solutions, such as the Stent-Graft System. This medical device is utilized to treat vascular conditions, particularly aneurysms or tears in blood vessels. It combines a stent, which provides structural support, with a graft made of synthetic material that lines the blood vessel. For example, in August 2024, Terumo India, a medical technology company based in India, launched the TREO Abdominal Stent-graft system. TREO is an advanced device specifically designed to treat abdominal aortic aneurysms, merging a durable stent with a biocompatible graft to offer effective support and reduce the risk of rupture. This system aims to improve patient outcomes by enabling minimally invasive procedures and enhancing long-term stability in vascular interventions.
In May 2023, Striker Corporation, a leading US-based medical technologies firm, completed the acquisition of Cerus Endovascular Ltd. for an undisclosed sum. This strategic acquisition is part of Striker Corporation's efforts to enhance its global portfolio of aneurysm treatment solutions. Cerus Endovascular Ltd., based in the UK, is a medical device company specializing in providing advanced solutions for the treatment of aneurysms.
Major companies operating in the aortic aneurysm market include Cardiatis SA, Cook Medical Inc., Endologix LLC, W L Gore & Associates Inc., JOTEC GmbH, Lombard Medical Limited., Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Endospan Ltd., LifeTech Scientific Corporation, B. Braun Melsungen AG, EndoEvolution LLC, CryoLife Inc., Intuitive Surgical Inc., Synovis Micro Companies Alliance Inc., Meril Life Sciences Pvt. Ltd., Vitalitec International GmbH, Getinge AB, CONMED Corporation, Becton, Dickinson and Company, Baxter International Inc., Johnson & Johnson Services Inc., Cardinal Health Inc., TriVascular Technologies Inc., Vascutek Ltd., Aptus Endosystems Inc., Bolton Medical Inc., EndoVascular Technologies Inc., Endurant Energy LLC, LeMaitre Vascular Inc.
North America was the largest region in the aortic aneurysm market in 2024. The regions covered in the aortic aneurysm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aortic aneurysm market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
An aortic aneurysm refers to a balloon-such as enlargement in the aorta, the principal artery responsible for carrying blood from the heart through the chest and torso. Factors such as certain medical conditions, genetic issues, and increased pressure can contribute to the weakening of the aorta, leading to the formation of an aneurysm. These aneurysms may take on a tube-shaped or round structure.
The primary types of aortic aneurysms include thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Thoracic aortic aneurysm (TAA) specifically occurs in the chest region due to a weakened area in the aorta. Various treatments are available, including open surgical repair (OSR) and endovascular aneurysm repair (EVAR), and these are commonly administered in hospitals, clinics, ambulatory surgery centers (ASCS), and other healthcare facilities.
The aortic aneurysm market research report is one of a series of new reports that provides aortic aneurysm market statistics, including aortic aneurysm industry global market size, regional shares, competitors with a aortic aneurysm market share, detailed aortic aneurysm market segments, market trends and opportunities, and any further data you may need to thrive in the aortic aneurysm industry. This aortic aneurysm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aortic aneurysm market includes revenues earned by entities by open surgery and endovascular repair. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The aortic aneurysm market size is expected to see rapid growth in the next few years. It will grow to $6.02 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to a rising global aging population, increased incidence of cardiovascular diseases, advancements in treatment modalities, genetic predisposition awareness, and healthcare infrastructure development. Major trends in the forecast period include the development of next-generation stent grafts, technological integration for remote monitoring, the prevalence of abdominal aortic aneurysms (AAA), and collaborations in research and development.
The anticipated rise in alcohol and tobacco usage is projected to drive the aortic aneurysm market in the future. Both alcohol and nicotine-containing tobacco products are psychoactive substances impacting the body's central nervous system. The increased consumption of these substances stands as a primary contributor to aortic aneurysms. As per a May 2022 report by the World Health Organization (WHO), an international public health agency headquartered in Switzerland, an estimated 3 million deaths annually are attributed to alcohol consumption, while 7 million deaths occur globally due to tobacco use. Moreover, approximately 13.5% of deaths among individuals aged 20-39 are linked to alcohol consumption. In 2021, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that 11.5% of US adults aged 18 or older were current cigarette smokers, amounting to 28.3 million adults. Hence, the increasing prevalence of alcohol and tobacco consumption is a key driver for the growth of the aortic aneurysm market.
The escalating occurrence of cardiovascular diseases is expected to fuel growth in the aortic aneurysm market. Cardiovascular diseases encompass a range of conditions affecting the heart or blood vessels. Devices tailored for aortic aneurysm treatment significantly contribute to managing cardiovascular diseases, especially those involving aortic aneurysms. For instance, data from May 2023 by the World Heart Federation, a non-governmental organization headquartered in Switzerland, indicated that in 2020, cardiovascular diseases led to 18.9 million fatalities, with forecasts indicating a rise to 22.2 million by 2030 and a further increase to 32.3 million by 2050. Consequently, the increasing incidence of cardiovascular diseases serves as a driving force behind the expansion of the aortic aneurysm market.
Technological advancements have become a prominent trend gaining traction in the aortic aneurysm market. Major companies in this sector are developing and implementing innovative technologies to solidify their market position. For example, in June 2024, Medtronic plc, a medical technology company based in Ireland, introduced the Steerant aortic guidewire, a device designed to enhance precision in aortic procedures. This flexible and advanced tool offers improved maneuverability and control during catheterization, allowing clinicians to navigate complex anatomical pathways more effectively and achieve better patient outcomes. Its goal is to reduce procedural time and minimize complications during aortic interventions.
Major companies in the aortic aneurysm market are concentrating on designing and introducing innovative solutions, such as the Stent-Graft System. This medical device is utilized to treat vascular conditions, particularly aneurysms or tears in blood vessels. It combines a stent, which provides structural support, with a graft made of synthetic material that lines the blood vessel. For example, in August 2024, Terumo India, a medical technology company based in India, launched the TREO Abdominal Stent-graft system. TREO is an advanced device specifically designed to treat abdominal aortic aneurysms, merging a durable stent with a biocompatible graft to offer effective support and reduce the risk of rupture. This system aims to improve patient outcomes by enabling minimally invasive procedures and enhancing long-term stability in vascular interventions.
In May 2023, Striker Corporation, a leading US-based medical technologies firm, completed the acquisition of Cerus Endovascular Ltd. for an undisclosed sum. This strategic acquisition is part of Striker Corporation's efforts to enhance its global portfolio of aneurysm treatment solutions. Cerus Endovascular Ltd., based in the UK, is a medical device company specializing in providing advanced solutions for the treatment of aneurysms.
Major companies operating in the aortic aneurysm market include Cardiatis SA, Cook Medical Inc., Endologix LLC, W L Gore & Associates Inc., JOTEC GmbH, Lombard Medical Limited., Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Endospan Ltd., LifeTech Scientific Corporation, B. Braun Melsungen AG, EndoEvolution LLC, CryoLife Inc., Intuitive Surgical Inc., Synovis Micro Companies Alliance Inc., Meril Life Sciences Pvt. Ltd., Vitalitec International GmbH, Getinge AB, CONMED Corporation, Becton, Dickinson and Company, Baxter International Inc., Johnson & Johnson Services Inc., Cardinal Health Inc., TriVascular Technologies Inc., Vascutek Ltd., Aptus Endosystems Inc., Bolton Medical Inc., EndoVascular Technologies Inc., Endurant Energy LLC, LeMaitre Vascular Inc.
North America was the largest region in the aortic aneurysm market in 2024. The regions covered in the aortic aneurysm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the aortic aneurysm market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
An aortic aneurysm refers to a balloon-such as enlargement in the aorta, the principal artery responsible for carrying blood from the heart through the chest and torso. Factors such as certain medical conditions, genetic issues, and increased pressure can contribute to the weakening of the aorta, leading to the formation of an aneurysm. These aneurysms may take on a tube-shaped or round structure.
The primary types of aortic aneurysms include thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Thoracic aortic aneurysm (TAA) specifically occurs in the chest region due to a weakened area in the aorta. Various treatments are available, including open surgical repair (OSR) and endovascular aneurysm repair (EVAR), and these are commonly administered in hospitals, clinics, ambulatory surgery centers (ASCS), and other healthcare facilities.
The aortic aneurysm market research report is one of a series of new reports that provides aortic aneurysm market statistics, including aortic aneurysm industry global market size, regional shares, competitors with a aortic aneurysm market share, detailed aortic aneurysm market segments, market trends and opportunities, and any further data you may need to thrive in the aortic aneurysm industry. This aortic aneurysm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aortic aneurysm market includes revenues earned by entities by open surgery and endovascular repair. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Aortic Aneurysm Market Characteristics3. Aortic Aneurysm Market Trends and Strategies4. Aortic Aneurysm Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Aortic Aneurysm Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Aortic Aneurysm Market34. Recent Developments in the Aortic Aneurysm Market
5. Global Aortic Aneurysm Growth Analysis and Strategic Analysis Framework
6. Aortic Aneurysm Market Segmentation
7. Aortic Aneurysm Market Regional and Country Analysis
8. Asia-Pacific Aortic Aneurysm Market
9. China Aortic Aneurysm Market
10. India Aortic Aneurysm Market
11. Japan Aortic Aneurysm Market
12. Australia Aortic Aneurysm Market
13. Indonesia Aortic Aneurysm Market
14. South Korea Aortic Aneurysm Market
15. Western Europe Aortic Aneurysm Market
16. UK Aortic Aneurysm Market
17. Germany Aortic Aneurysm Market
18. France Aortic Aneurysm Market
19. Italy Aortic Aneurysm Market
20. Spain Aortic Aneurysm Market
21. Eastern Europe Aortic Aneurysm Market
22. Russia Aortic Aneurysm Market
23. North America Aortic Aneurysm Market
24. USA Aortic Aneurysm Market
25. Canada Aortic Aneurysm Market
26. South America Aortic Aneurysm Market
27. Brazil Aortic Aneurysm Market
28. Middle East Aortic Aneurysm Market
29. Africa Aortic Aneurysm Market
30. Aortic Aneurysm Market Competitive Landscape and Company Profiles
31. Aortic Aneurysm Market Other Major and Innovative Companies
35. Aortic Aneurysm Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Aortic Aneurysm Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on aortic aneurysm market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for aortic aneurysm? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aortic aneurysm market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Thoracic Aortic Aneurysm (TAA); Abdominal Aortic Aneurysm (AAA)2) By Treatment: Open Surgical Repair (OSR); Endovascular Aneurysm Repair (EVAR)
3) By End User: Hospitals and Clinics; Ambulatory Surgery Centers (ASCs); Other End Users
Subsegments:
1) By Thoracic Aortic Aneurysm (TAA): Ascending Aortic Aneurysm; Arch Aortic Aneurysm; Descending Aortic Aneurysm2) By Abdominal Aortic Aneurysm (AAA): Infrarenal Aneurysm; Pararenal Aneurysm; Juxtarenal Aneurysm
Key Companies Mentioned: Cardiatis SA; Cook Medical Inc.; Endologix LLC; W L Gore & Associates Inc.; JOTEC GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Cardiatis SA
- Cook Medical Inc.
- Endologix LLC
- W L Gore & Associates Inc.
- JOTEC GmbH
- Lombard Medical Limited.
- Medtronic plc
- Terumo Corporation
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Endospan Ltd.
- LifeTech Scientific Corporation
- B. Braun Melsungen AG
- EndoEvolution LLC
- CryoLife Inc.
- Intuitive Surgical Inc.
- Synovis Micro Companies Alliance Inc.
- Meril Life Sciences Pvt. Ltd.
- Vitalitec International GmbH
- Getinge AB
- CONMED Corporation
- Becton, Dickinson and Company
- Baxter International Inc.
- Johnson & Johnson Services Inc.
- Cardinal Health Inc.
- TriVascular Technologies Inc.
- Vascutek Ltd.
- Aptus Endosystems Inc.
- Bolton Medical Inc.
- EndoVascular Technologies Inc.
- Endurant Energy LLC
- LeMaitre Vascular Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 4.07 Billion |
| Forecasted Market Value ( USD | $ 6.02 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
